    |
||||
 |
||||
 |
||||
News CryoCath to Hold Second Quarter 2008 Conference Call and WebcastMontreal, Canada - May 1, 2008 - CryoCath (TSX: CYT), will hold a conference call to discuss its second quarter 2008 financial results at 4:30 p.m. (Eastern Time) on Monday, May 12, 2008. The Company will report its results in a press release to be issued at 4:00 p.m. on Monday, May 12. DATE: Monday, May 12, 2008 About Medtronic CryoCathCryoCath – www.cryocath.com – is a medical technology company that leads the world in cryotherapy products to treat cardiac arrhythmias. With a priority focus on providing physicians with a complete solution of catheter products to treat cardiac arrhythmias, CryoCath has multiple products approved in the U.S., across Europe and several ROW countries. The Company is developing additional products to expand its pipeline of products to treat cardiac arrhythmias. This press release includes "forward-looking statements" that are subject to risks and uncertainties, including with respect to the timing of regulatory trials and their outcome. For information identifying legislative or regulatory, economic, climatic, currency, technological, competitive and other important factors that could cause actual results to differ materially from those anticipated in the forward looking statements, see CryoCath's annual report available at www.sedar.com under the heading Risks and Uncertainties in the Management's Discussion and Analysis section. For further information, please contact:
|
||||
|
||||
